- Home
- DHIL vs ZURA Comparison
DHIL vs ZURA Comparison
Compare DHIL & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHIL
- ZURA
- Stock Information
- Founded
- DHIL 1990
- ZURA 2022
- Country
- DHIL United States
- ZURA United States
- Employees
- DHIL N/A
- ZURA N/A
- Industry
- DHIL Investment Managers
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DHIL Finance
- ZURA Health Care
- Exchange
- DHIL Nasdaq
- ZURA Nasdaq
- Market Cap
- DHIL N/A
- ZURA 76.6M
- IPO Year
- DHIL 1995
- ZURA N/A
- Fundamental
- Price
- DHIL $139.61
- ZURA $1.26
- Analyst Decision
- DHIL
- ZURA Buy
- Analyst Count
- DHIL 0
- ZURA 7
- Target Price
- DHIL N/A
- ZURA $14.67
- AVG Volume (30 Days)
- DHIL 15.1K
- ZURA 333.9K
- Earning Date
- DHIL 04-29-2025
- ZURA 05-08-2025
- Dividend Yield
- DHIL 4.33%
- ZURA N/A
- EPS Growth
- DHIL 0.69
- ZURA N/A
- EPS
- DHIL 14.79
- ZURA N/A
- Revenue
- DHIL $151,916,411.00
- ZURA N/A
- Revenue This Year
- DHIL N/A
- ZURA N/A
- Revenue Next Year
- DHIL N/A
- ZURA N/A
- P/E Ratio
- DHIL $9.27
- ZURA N/A
- Revenue Growth
- DHIL 9.28
- ZURA N/A
- 52 Week Low
- DHIL $122.32
- ZURA $0.97
- 52 Week High
- DHIL $173.25
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- DHIL 60.69
- ZURA 45.99
- Support Level
- DHIL $122.32
- ZURA $1.17
- Resistance Level
- DHIL $136.40
- ZURA $1.55
- Average True Range (ATR)
- DHIL 2.71
- ZURA 0.14
- MACD
- DHIL 1.77
- ZURA -0.01
- Stochastic Oscillator
- DHIL 95.09
- ZURA 17.61
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.